tiprankstipranks

Daniel A. Camardo Insider Profile

18 Followers
Daniel A. Camardo, Director at Cue Biopharma, holds 21.80K shares in Cue Biopharma (Ticker: CUE), holds 285.34K shares in Athersys (Ticker: ATHXQ), holds 51.18K shares in Horizon Therapeutics (Ticker: HZNP).
tipranks
Daniel A. Camardo

Daniel A. Camardo
Cue Biopharma (CUE)
Director

Ranked #96,142 out of 108,921 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-70.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$654K
100.00%
0.00%
A breakdown of Daniel A. Camardo's holdings

Insider Roles

Cue Biopharma
(CUE)
Director
Athersys
(ATHXQ)
CEO, Director
Roles that Daniel A. Camardo holds in companies

Most Profitable Insider Trade

Stock:
Horizon Therapeutics
(HZNP)
Rating:Informative Sell
Date:Nov 06, 2020 - Nov 06, 2021
Return:-46.60%
The most profitable trade made by Daniel A. Camardo

Daniel A. Camardo's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cue Biopharma
Jul 10, 2026
Director
Uninformative Buy
$654.00K
HZNP
Horizon Therapeutics
Mar 31, 2021
Uninformative Sell
1.10M
$5.95M
Athersys
Oct 06, 2023
CEO, Director
Uninformative Sell
8.80K
List of latest transactions for each holding click on a transaction to see Daniel A. Camardo's performance on stock

Daniel A. Camardo insider profile FAQ

What is the percentage of profitable transactions made by Daniel A. Camardo?
The percentage of profitable transactions made by Daniel A. Camardo is 0%.
    What is the average return per transaction made by Daniel A. Camardo?
    The average return per transaction made by Daniel A. Camardo is -70.10%.
      What stocks does Daniel A. Camardo hold?
      Daniel A. Camardo holds: CUE, HZNP, ATHXQ stocks.
        What was Daniel A. Camardo’s latest transaction?
        Daniel A. Camardo latest transaction was an Uninformative Buy of ―.
          What was Daniel A. Camardo's most profitable transaction?
          Daniel A. Camardo’s most profitable transaction was an Informative Sell of HZNP stock on November 6, 2020. The return on the trade was -46.60%.
            What is Daniel A. Camardo's role in Cue Biopharma?
            Daniel A. Camardo's role in Cue Biopharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.